Burcu Tunakan: Turning Collaboration into Better Outcomes for People with Hemophilia
Burcu Tunakan, Vice President of US Hematology and Endocrinology Franchise Lead at Pfizer, shared a post on LinkedIn:
“Today, we were thrilled to host our second Hemophilia Day at Pfizer Headquarters.
Leading Hematologists across the nation joined us for a day of candid dialogue and collaboration, at a time when the science in this space is advancing faster than ever.
We exchanged perspectives and insights which will shape our team’s actions to advance care for people living with Hemophilia.
Because there is still meaningful work ahead.
And our team is fully committed to turning breakthrough innovation into real, lasting patient impact, by listening deeply and working alongside this community every step of the way.
Thank you to every leading expert who joined us.
Your partnership makes the difference.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge